Nmnat2 | nicotinamide nucleotide adenylyltransferase 2
Physiological systems
22 / 24 physiological systems tested
8 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Embryo Growth/size/body region Nervous system Vision/eye Mortality/aging Cardiovascular system
14 No significant impact
2 Not tested
Data collections
Gene metrics:11Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
edema | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | homozygote | E15.5 | N/A * | ||
embryonic growth retardation | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | homozygote | E15.5 | N/A * | ||
abnormal placenta vasculature | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | homozygote | E15.5 | N/A * | ||
abnormal placenta morphology | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
abnormal blood vessel morphology | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
abnormal placenta morphology | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | homozygote | E15.5 | N/A * | ||
microphthalmia | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
preweaning lethality, complete penetrance | 3 supporting datasets | Nmnat2em1(IMPC)Mbp | homozygote | Early adult | N/A * | ||
abnormal blood vessel morphology | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | homozygote | E15.5 | N/A * | ||
abnormal lymph node morphology | 1 supporting dataset | Nmnat2em1(IMPC)Mbp | heterozygote | Early adult | N/A * |
| | | | | | | | | |
External links
No external links available for Nmnat2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Nmnat2em1(IMPC)Mbp | Exon Deletion | | mouse |
Nmnat2tm296362(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |